HDL cholesterol and cardiovascular risk: teasing the answer from the complexity

被引：4
|
作者：
Nicholls, Stephen J. [1 ]
Fujino, Masashi [1 ]
机构：
[1] Monash Univ, Victorian Heart Inst, 246 Clayton Rd, Clayton, Vic 3168, Australia
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2023年 / 30卷 / 08期
关键词：
HIGH-DENSITY-LIPOPROTEIN;
D O I：
10.1093/eurjpc/zwad074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：644 / 645
页数：2
相关论文
共 50 条
  • [31] Effect of historical changes in HDL-cholesterol measurements on cardiovascular risk assessment
    Marrington, R.
    Webster, C.
    Jewkes, C.
    Jones, A.
    ATHEROSCLEROSIS, 2011, 218 (02) : E2 - E2
  • [32] HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
    Bhatt, Anish
    Rohatgi, Anand
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01) : 1 - 8
  • [33] HDL CHOLESTEROL AND CORONARY RISK
    DEBACKER, G
    KORNITZER, M
    DRAMAIX, M
    SOBOLSKI, J
    DEGRE, S
    PANNIER, R
    DENOLIN, H
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1980, 29 (06): : 431 - 437
  • [34] ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
    de Nijs, Tjerk
    Sniderman, Allan
    de Graaf, Jacqueline
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (06) : 163 - 171
  • [35] Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor
    Bos, G
    Dekker, JM
    Heine, R
    DIABETES CARE, 2004, 27 (01) : 283 - 284
  • [36] Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
    Hansen, M. K.
    Olesen, K. K. W.
    Thrane, P. G.
    Gyldenkerne, C.
    Stoedkilde-Joergensen, N.
    Andersen, M. H.
    Maeng, M.
    Mortensen, M. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] A Retrospective Analysis of Non-HDL Cholesterol: For Improved Cardiovascular Risk Assessment
    Khan, Sohail Rafi
    Mukhtar, Ana
    Ahmed, Altaf
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2015, 20 (02): : 97 - 102
  • [38] Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
    Holewijn, S.
    den Heijer, M.
    Swinkels, D. W.
    Stalenhoef, A. F. H.
    de Graaf, J.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (06) : 567 - 577
  • [39] LIPOPROTEINS AND LIPID METABOLISM: HDL. HDL CHOLESTEROL EFFLUX IS NOT PREDICTIVE OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS ON HEMODIALYSIS
    Kopecky, C.
    Ebtehaj, S.
    Genser, B.
    Wanner, C.
    Saemann, M. D.
    Tietge, U.
    ATHEROSCLEROSIS, 2016, 252 : E107 - E107
  • [40] COMPARISON OF CHOLESTEROL-HDL RATIO, LDL-HDL RATIO AND LIPOPROTEIN PHENOTYPING IN THE ASSESSMENT OF CARDIOVASCULAR RISK
    BURGESS, TE
    BLUM, L
    FUREY, K
    CLINICAL CHEMISTRY, 1980, 26 (07) : 965 - 965
12345